Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Kymera Therapeutics (KYMR)

Tipranks - Tipranks - Sat May 2, 9:16AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenet Healthcare (THC) and Kymera Therapeutics (KYMR) with bullish sentiments.

Claim 55% Off TipRanks

Tenet Healthcare (THC)

Truist Financial analyst David S Macdonald reiterated a Buy rating on Tenet Healthcare today. The company’s shares closed last Friday at $187.48.

According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 10.6% and a 58.5% success rate. Macdonald covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Concentra Group Holdings Parent, Inc., and Ardent Health Partners, Inc. ;'>

Currently, the analyst consensus on Tenet Healthcare is a Strong Buy with an average price target of $254.08, which is a 41.9% upside from current levels. In a report released today, TipRanks – DeepSeek also upgraded the stock to Buy with a $200.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Kymera Therapeutics (KYMR)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Kymera Therapeutics today. The company’s shares closed last Friday at $81.69.

According to TipRanks.com, Devarakonda is a 5-star analyst with an average return of 15.4% and a 52.0% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Protagonist Therapeutics, and Madrigal Pharmaceuticals. ;'>

Currently, the analyst consensus on Kymera Therapeutics is a Strong Buy with an average price target of $121.50, a 49.1% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy rating on the stock.

Read More on THC:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).